Cargando…

Advances in multiple myeloma therapy during two past decades

Multiple myeloma (MM) is a clonal B-cell malignancy characterized by aberrant expansion of plasma cells within bone marrow and extramedullary sites. It is one of the most common haematological malignancies; it accounts for 1.4% of all tumours and is responsible for 2% of cancer-related mortality. Ov...

Descripción completa

Detalles Bibliográficos
Autor principal: Spicka, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151869/
https://www.ncbi.nlm.nih.gov/pubmed/25210597
http://dx.doi.org/10.1016/j.csbj.2014.05.005